Virpax appoints Charn Deol to board; Jaydriane Panis resigns

Virpax Pharmaceuticals, Inc.

Jaydriane Panis resigned from board on Feb 3, 2025; Charn Deol appointed Feb 5, 2025.
Deol appointed Chair of Audit Committee, member of Compensation and Nominating Committees.
Deol receives CAD $3,000/month consulting fee payable to Spiral Investment Corp., his company.
Deol has over 35 years public company experience, currently director/CFO at several companies.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jaydriane Panis

Director

Virpax Pharmaceuticals, Inc.

Effective: 2025-02-03
Successor: Charn Deol
Filed: February 6, 2025, 6:59 PM ET

Jaydriane (Jay) Panis, who resigned from the Board on February 3, 2025.

Appointed

Charn Deol

Director

Virpax Pharmaceuticals, Inc.

Effective: 2025-02-05
Filed: February 6, 2025, 6:59 PM ET

appointed Mr. Charn Deol as an independent director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jaydriane Panis resigned as Director at Virpax Pharmaceuticals, Inc..

Action: resigned
Role: Director

Exact text from the filing

Jaydriane (Jay) Panis, who resigned from the Board on February 3, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Charn Deol was appointed as Director at Virpax Pharmaceuticals, Inc..

Action: appointed
Role: Director

Exact text from the filing

appointed Mr. Charn Deol as an independent director of the Company, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001731122-25-000178

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.